HENT1 AND DCK EXPRESSION PREDICT BENEFIT FROM GEMCITABINE AFTER CURATIVE-INTENT RESECTION IN PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Marechal, Raphael [1 ]
Bachet, Jean-Baptiste [2 ]
Mackey, John R. [3 ]
Demetter, Pieter [1 ]
Graham, Kathryn [3 ]
Couvelard, Anne [4 ]
Svrcek, Magali [5 ]
Bardier-Dupas, Armelle [2 ]
Hammel, Pascal [4 ]
Sauvanet, Alain [4 ]
Louvet, Christophe [5 ]
Paye, Francois [5 ]
Rougier, Philippe [6 ]
Hannoun, Laurent [2 ]
Andre, Thierry [2 ]
Cass, Carol E. [3 ]
Salmon, Isabelle [1 ]
Emile, Jean-Francois [7 ]
Van Laethem, Jean-Luc [1 ]
机构：
[1] Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium
[2] Hop La Pitie Salpetriere, Paris, France
[3] Univ Alberta, Cross Canc Inst, Edmonton, AB T6G 2M7, Canada
[4] Hop Beaujon, Paris, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Europeen Georges Pompidou, Paris, France
[7] Hop Ambroise Pare, Paris, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v12 / v12
页数：1
相关论文
共 50 条
  • [21] Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy
    Bird, N. T. E.
    Elmasry, M.
    Jones, R.
    Psarelli, E.
    Dodd, J.
    Malik, H.
    Greenhalf, W.
    Kitteringham, N.
    Ghaneh, P.
    Neoptolemos, J. P.
    Palmer, D.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (04) : 328 - 336
  • [22] High hENT1 Expression is Predictive of Response of to Adjuvant Gemcitabine for Pancreatic Ductal Adenocarcinoma Patients Randomized to Adjuvant Therapies in the ESPAC Trials
    Neoptolemos, J. P.
    Cox, T. F.
    Greenhalf, W.
    Garner, L.
    Campbell, F.
    Ghaneh, P.
    Palmer, D.
    Mackey, J.
    Dervenis, C.
    Scarpa, A.
    Bassi, C.
    Buechler, M. W.
    PANCREAS, 2012, 41 (08) : 1390 - 1390
  • [23] Adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunostaining in curative resected pancreatic adenocarcinoma: A biomaker stratified trial.
    Shin, Dong Woo
    Kim, Min Jae
    Yang, Se Yeol
    Lee, Jong-chan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
    Oettle, Helmut
    Post, Stefan
    Neuhaus, Peter
    Gellert, Klaus
    Langrehr, Jan
    Ridwelski, Karsten
    Schramm, Harald
    Fahlke, Joerg
    Zuelke, Carl
    Burkart, Christof
    Gutberlet, Klaus
    Kettner, Erika
    Schmalenberg, Harald
    Weigang-Koehler, Karin
    Bechstein, Wolf-Otto
    Niedergethmann, Marco
    Schmidt-Wolf, Ingo
    Roll, Lars
    Doerken, Bernd
    Riess, Hanno
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03): : 267 - 277
  • [25] Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study
    Ecker, B. L.
    McMillan, M. T.
    Datta, J.
    Dempsey, D. T.
    Karakousis, G. C.
    Fraker, D. L.
    Drebin, J. A.
    Mamtani, R.
    Giantonio, B. J.
    Roses, R. E.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : 135 - 141
  • [26] Can hENT1 Expression in EUS-FNAB Samples be the Prognostic Factor of Pancreatic Ductal Adenocarcinoma Before Gemcitabine-based Chemoradiotherapy?
    Yamada, R.
    Mizuno, S.
    Inoue, H.
    Murata, Y.
    Kuriyama, N.
    Azumi, Y.
    Kishiwada, M.
    Usui, M.
    Sakurai, Y.
    Isaji, S.
    PANCREAS, 2014, 43 (08) : 1425 - 1425
  • [27] ASO Author Reflections: A Nomogram to Predict Recurrence after Curative-Intent Resection for Neuroendocrine Liver Metastasis
    Tsilimigras, Diamantis I.
    Xiang, Jun-Xi
    Zhang, Xu-Feng
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 3727 - 3728
  • [28] Risk stratification of pancreatic ductal adenocarcinoma patients undergoing curative-intent surgery after neoadjuvant therapy
    Yang, Hyun Kyung
    Park, Mi-Suk
    Han, Kyunghwa
    Eom, Geonsik
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] ASO Author Reflections: A Nomogram to Predict Recurrence after Curative-Intent Resection for Neuroendocrine Liver Metastasis
    Diamantis I. Tsilimigras
    Jun-Xi Xiang
    Xu-Feng Zhang
    Timothy M. Pawlik
    Annals of Surgical Oncology, 2020, 27 : 3727 - 3728
  • [30] Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
    Yang, Hyun Kyung
    Park, Mi-Suk
    Han, Kyunghwa
    Eom, Geonsik
    Chung, Yong Eun
    Choi, Jin-Young
    Bang, Seungmin
    Kang, Chang Moo
    Seong, Jinsil
    Kim, Myeong-Jin
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 247 - 258
12345